McAndrew Rudisill - Aug 4, 2025 Form 3 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
Director
Signature
/s/ McAndrew Rudisill
Stock symbol
ATNF
Transactions as of
Aug 4, 2025
Transactions value $
$0
Form type
3
Date filed
8/7/2025, 04:20 PM
Previous filing
Jun 14, 2024
Next filing
Aug 12, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rudisill McAndrew Director 3000 EL CAMINO REAL, BLDG. 4, SUITE 200, PALO ALTO /s/ McAndrew Rudisill 2025-08-07 0001511937

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATNF Common Stock 37.7K Aug 4, 2025 By BER I LLC F1
holding ATNF Common Stock 37.7K Aug 4, 2025 By GER I LLC F2
holding ATNF Common Stock 37.7K Aug 4, 2025 By MRR I LLC F3
holding ATNF Common Stock 453K Aug 4, 2025 By Pelagic Capital Advisors LLC F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ATNF Warrants to Purchase Common Stock Aug 4, 2025 Common Stock 4.81M $2.78 By PCAO LLC F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is the managing partner of BER I LLC ("BER"), and therefore may be deemed to beneficially own the securities held by BER. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by BER, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F2 The Reporting Person is the managing partner of GER I LLC ("GER"), and therefore may be deemed to beneficially own the securities held by GER. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by GER, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F3 The Reporting Person is the managing partner of MRR I LLC ("MRR"), and therefore may be deemed to beneficially own the securities held by MRR. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by MRR, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F4 The Reporting Person is the managing partner and founder of Pelagic Capital Advisors LLC ("Pelagic"), and therefore may be deemed to beneficially own the securities held by Pelagic. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by Pelagic, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F5 These warrants are currently exercisable, subject to a blocker provision that prevents PCAO (defined below) from exercising the warrants if it would be more than a 4.99% beneficial owner of the outstanding shares of the Issuer's common stock following such exercise, which percentage may be increased to up to 19.99% with at least 61 days prior written notice to the Issuer.
F6 The warrants have no expiration date.
F7 The Reporting Person is the managing partner of PCAO LLC ("PCAO"), and therefore may be deemed to beneficially own the securities held by such entity. Mr. Rudisill disclaims beneficial ownership of the shares of securities owned directly by PCAO, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.